Peptor
	Developer of products to treat autoimmune diseases. The company develops small cyclical analogues of peptide loop drugs to treat cancer, bacterial and fungal infections, autoimmune diseases, multiple sclerosis and other disorders.
	['', 'autoimmune product', ' ', 'protein treatment', ' ', 'healthcare service', '']
Chronogen
	Developer of small-molecule drugs to treat oxidative stress and lipid disorders in age-related diseases. The company develops human therapeutics to treat age-dependent diseases, with an initial focus on cardiovascular disorders and cancer.
	['', 'small-molecule drugs', ' ', 'human therapeutics', ' ', 'pharmaceutical industry', '']
Small Bone Innovations (Ankle Replacement System & Other Assets)
	The company provides ankle replacement system. The unit offers a portfolio of products and technologies to treat trauma and diseases in the small bones & joints.
	['ankle ', 'replacement system', ' ', 'surgical device', '']
Elitra Phramaceuticals
	Developer of next generation antimicrobial drugs that target essential gene products of pathogenic organisms. The company employs its functional genomics technologies to identify essential gene drug targets in clinically relevant bacterial and fungal pathogens.
	['', 'antimicrobial drug', ' ', 'drug discovery', ' ', 'pathogenic organism', '']
Endocyte
	Developer of receptor-targeted therapeutics for the treatment of cancer and autoimmune diseases. The company provides EC17, a folate-targeted hapten therapy drug to treat metastatic renal and ovarian cancer; EC145, a folate-targeted chemotherapeutic conjugate to treat various tumors, including cancers of the breast, lung, and blood; EC0225, a targeted chemotherapy drug.
	['', 'cancer treatment', ' ', 'autoimmune disease', ' ', 'ovarian cancer', ' ', 'breast cancer', '']
Avidex
	Operator of a biotechnology company focused on the development of therapeutics for cancer and autoimmune diseases. The company develops small molecule modulators of T cell function and protein therapeutics based on T cell receptors. The technology enables the company to develop treatments for cancer, inflammation, autoimmune diseases and allergies.
	['', 'T cell', ' mTCR ', 'autoimmune disease', ' ', 'cancer therapy', '']
Catalyst Pharmaceutical Partners
	Developer of a pharmaceutical company. The company focuses on in-licensing, developing and commercializing prescription drugs to treat rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms and Tourette\'s disorder.
	['in-licensing ', 'prescription drugs', ' spasms']
Allostera Pharma
	The company also developes allosteramers for inflammation and autoimmune diseases. The company\'s lead products target the insulin-like growth factor-1 receptor (IGF-1R)for cancer.
	['', 'inflammation disease', ' ', 'autoimmune disease', '']
